Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Tags:
Pfizer, danuglipron, Novo Nordisk, Ozempic, weight loss
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Medwatch
Sun, 06/4/23 - 04:19 pm
Tags:
Novo Nordisk, insulin, diabetes, drug pricing
Novo Nordisk wins age discrimination case in US district court
Medwatch
Sun, 06/4/23 - 04:17 pm
Tags:
Novo Nordisk, age discrimination, legal, EEOC
Novo seeks a cardiovascular boost
EP Vantage
Thu, 06/1/23 - 11:23 am
Tags:
Novo Nordisk, Wegovy, Eli Lilly, Mounjaro
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
Tags:
obesity, weight loss, Novo Nordisk, Eli Lilly, Pfizer, Amgen
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Wed, 05/31/23 - 10:56 am
Tags:
Novo Nordisk, weight loss, Wegovy, oral Wegovy
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Tue, 05/30/23 - 10:07 am
Tags:
Pfizer, Novo Nordisk, clinical trials, hemophilia, marstacimab
Noom to offer prescriptions for weight-loss drugs
Yahoo Finance
Fri, 05/26/23 - 10:05 am
Tags:
Noom, weightloss, Novo Nordisk, Eli Lilly, Wegovy, Ozempic, Mounjaro
Novo marks a century in business with corporate campaign launch
Medical Marketing and Media
Wed, 05/24/23 - 06:48 pm
Tags:
Novo Nordisk, corporate branding
Novo makes a gene editing move
EP Vantage
Wed, 05/24/23 - 10:20 am
Tags:
Novo Nordisk, gene editing, Life Edit Therapeutics
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Tue, 05/23/23 - 11:19 am
Tags:
Pfizer, Novo Nordisk, weight loss, Ozempic, danuglipron, clinical trials
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Tue, 05/23/23 - 09:56 am
Tags:
Novo Nordisk, semaglutide, oral semaglutide, clinical trials, weight loss
Novo Nordisk pauses Wegovy marketing projects to dampen demand
Fierce Pharma
Mon, 05/22/23 - 11:52 am
Tags:
Novo Nordisk, Wegovy, weight loss, DTC advertising
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
Wed, 05/10/23 - 11:15 pm
Tags:
PBMs, insulin, diabetes, drug pricing, Sanofi, Novo Nordisk, Eli Lilly
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Gilead Sciences, Horizon Therapeutics, Merck, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi
‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
Stat
Tue, 05/9/23 - 10:33 am
Tags:
side effects, Ozempic, Wegovy, Mounjaro, Novo Nordisk, Eli Lilly, obesity
Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy
Fierce Pharma
Thu, 05/4/23 - 09:05 pm
Tags:
Novo Nordisk, Wegovy, obesity
Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up
Yahoo/Zacks.com
Thu, 05/4/23 - 08:51 pm
Tags:
Novo Nordisk, earnings
In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy
Fierce Pharma
Mon, 04/24/23 - 10:20 am
Tags:
Eli Lilly, clinical trials, obesity, Mounjaro, Novo Nordisk, Wegovy
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D, Amgen, Bayer, Biogen, Gilead Sciences, Merck KGaA, Moderna Therapeutics, Novo Nordisk, Regeneron Pharmaceuticals, UCB, Vertex Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.